UK Biobank Imaging Enhancement Main phase
英国生物银行成像增强主阶段
基本信息
- 批准号:MC_PC_15067
- 负责人:
- 金额:$ 1190.91万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Intramural
- 财政年份:2016
- 资助国家:英国
- 起止时间:2016 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The challenges of understanding the determinants of common life-threatening and disabling diseases are substantial. Such conditions are typically caused by many different exposures that each have moderate effects and interact with each other in complex ways. Prospective cohorts, such as UK Biobank, have advantages for the comprehensive and reliable quantification of the combined effects of different types of risk factor on health outcomes. In particular, exposures can be assessed before they are affected by disease or its management, and diseases can be assessed that are not readily investigated by retrospective studies (e.g. dementia). Moreover, all of the beneficial and adverse effects of a specific factor on the life-time risks of different diseases can be considered. Prospective studies do, however, need to involve large numbers of participants because only a relatively small proportion will develop any particular condition. UK Biobank has involved the collection of extensive baseline questionnaire data, physical measurements and biological samples from 500,000 men and women aged 40-69 at baseline, and their health is now being followed long-term. This proposal is for enhanced phenotyping of 100,000 of the participants with a set of imaging modalities that have been carefully chosen to provide considerable additional information that is likely to be relevant to many different health outcomes.
了解常见的危及生命和致残疾病的决定因素是一项巨大的挑战。这种情况通常是由许多不同的暴露引起的,每种暴露都有适度的影响,并以复杂的方式相互作用。前瞻性队列,如英国生物库,具有全面和可靠的量化不同类型的风险因素对健康结果的综合影响的优势。特别是,可以在接触受到疾病或其管理影响之前对其进行评估,并且可以评估那些不容易通过回顾性研究进行调查的疾病(例如痴呆症)。此外,可以考虑特定因素对不同疾病的终生风险的所有有利和不利影响。然而,前瞻性研究确实需要涉及大量的参与者,因为只有相对较小的比例会出现任何特定的情况。英国生物银行收集了广泛的基线问卷数据,身体测量和基线时40-69岁的50万男性和女性的生物样本,他们的健康状况正在长期跟踪。该提案是为了增强100,000名参与者的表型,使用一组经过精心选择的成像模式,以提供可能与许多不同健康结果相关的大量额外信息。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Genetic architecture of brain age and its causal relations with brain and mental disorders.
脑时代的遗传结构及其与脑和精神障碍的因果关系。
- DOI:10.1038/s41380-023-02087-y
- 发表时间:2023-07
- 期刊:
- 影响因子:11
- 作者:Leonardsen, Esten. H.;Vidal-Pineiro, Didac;Roe, James. M.;Frei, Oleksandr;Shadrin, Alexey. A.;Iakunchykova, Olena;de Lange, Ann-Marie G.;Kaufmann, Tobias;Taschler, Bernd;Smith, Stephen. M.;Andreassen, Ole. A.;Wolfers, Thomas;Westlye, Lars. T.;Wang, Yunpeng
- 通讯作者:Wang, Yunpeng
New Horizons: the value of UK Biobank to research on endocrine and metabolic disorders.
- DOI:10.1210/clinem/dgac407
- 发表时间:2022-08-18
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
A longitudinal genome-wide association study of bone mineral density mean and variability in the UK Biobank
- DOI:10.1007/s00198-023-06852-1
- 发表时间:2023-07
- 期刊:
- 影响因子:4
- 作者:D. He;Huan Liu;Wenming Wei;Yijing Zhao;Q. Cai;S. Shi;Xiaoge Chu;X. Qin;Na Zhang;P. Xu;Feng Zhang
- 通讯作者:D. He;Huan Liu;Wenming Wei;Yijing Zhao;Q. Cai;S. Shi;Xiaoge Chu;X. Qin;Na Zhang;P. Xu;Feng Zhang
Cohort profile: rationale and methods of UK Biobank repeat imaging study eye measures to study dementia.
- DOI:10.1136/bmjopen-2022-069258
- 发表时间:2023-06-23
- 期刊:
- 影响因子:2.9
- 作者:
- 通讯作者:
UK Biobank: opportunities for cardiovascular research.
- DOI:10.1093/eurheartj/ehx254
- 发表时间:2019-04-07
- 期刊:
- 影响因子:39.3
- 作者:Littlejohns TJ;Sudlow C;Allen NE;Collins R
- 通讯作者:Collins R
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rory Collins其他文献
Procédés pour diagnostiquer la susceptibilité à la myopathie induite par la statine.
他汀类肌病易感性诊断程序。
- DOI:
10.1002/9781119959601.ch7 - 发表时间:
2009 - 期刊:
- 影响因子:4.3
- 作者:
Emma Link;Sarah Parish;Rory Collins;M. Lathrop - 通讯作者:
M. Lathrop
Hyperuricemia, gout and the associated comorbidities in China: findings from a prospective study of 0.5 million adults
中国高尿酸血症、痛风及相关合并症:一项针对 50 万成年人的前瞻性研究结果
- DOI:
10.1016/j.lanwpc.2025.101572 - 发表时间:
2025-05-01 - 期刊:
- 影响因子:8.100
- 作者:
Pek Kei Im;Christiana Kartsonaki;Maria G. Kakkoura;Olaa Mohamed-Ahmed;Ling Yang;Yiping Chen;Huaidong Du;Xiaoming Yang;Hua Zhang;Dianjianyi Sun;Canqing Yu;Jun Lv;Liming Li;Zhengming Chen;Iona Y. Millwood;Junshi Chen;Zhengming Chen;Robert Clarke;Rory Collins;Liming Li;Yan Zhao - 通讯作者:
Yan Zhao
Increased risk of early and late mortality with first degree heart block in patients with acute myocardial infarction
- DOI:
10.1016/0735-1097(90)92511-y - 发表时间:
1990-02-01 - 期刊:
- 影响因子:
- 作者:
Salim Yusuf;Rory Collins; The of Infarct Survial (ISIS) collaborative group - 通讯作者:
The of Infarct Survial (ISIS) collaborative group
Randomized trial of cholesterol-lowering, and of antioxidant vitamins, in 6,000 people with diabetes mellitus
- DOI:
10.1016/s0735-1097(02)81095-6 - 发表时间:
2002-03-06 - 期刊:
- 影响因子:
- 作者:
Rory Collins;Jane Armitage;Sarah Parish;Peter Sleight;Richard Peto - 通讯作者:
Richard Peto
Randomized trial of cholesterol-lowering and antioxidant vitamins in 5,000 women at high-risk of coronary heart disease
- DOI:
10.1016/s0735-1097(02)81097-x - 发表时间:
2002-03-06 - 期刊:
- 影响因子:
- 作者:
Rory Collins;Jane Armitage;Sarah Parish;Peter Sleight;Richard Peto - 通讯作者:
Richard Peto
Rory Collins的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rory Collins', 18)}}的其他基金
Biobank Re-imaging Study co-funded by Medical Research Council (MRC), Chan Zuckerberg Initiative (CZI) and Calico Life Sciences LLC (Calico)
生物样本库重新成像研究由医学研究委员会 (MRC)、Chan Zuckerberg Initiative (CZI) 和 Calico Life Sciences LLC (Calico) 共同资助
- 批准号:
MC_PC_21035 - 财政年份:2022
- 资助金额:
$ 1190.91万 - 项目类别:
Intramural
SARS-CoV 2 imaging study award to the UK Biobank
英国生物银行获得 SARS-CoV 2 成像研究奖
- 批准号:
MC_PC_21051 - 财政年份:2021
- 资助金额:
$ 1190.91万 - 项目类别:
Intramural
UKRI Industrial Strategy Challenge Fund UK BioBank Vanguard Project - Whole Genome Sequencing
UKRI 产业战略挑战基金英国生物银行先锋项目 - 全基因组测序
- 批准号:
MC_PC_17223 - 财政年份:2018
- 资助金额:
$ 1190.91万 - 项目类别:
Intramural
UKRI Industrial Strategy Challenge Fund UK BioBank Vanguard Project - Informatics
UKRI 产业战略挑战基金英国生物银行先锋项目 - 信息学
- 批准号:
MC_PC_18026 - 财政年份:2018
- 资助金额:
$ 1190.91万 - 项目类别:
Intramural
UK Biobank pilot imaging enhancement
英国生物银行试点成像增强
- 批准号:
MC_PC_12027 - 财政年份:2013
- 资助金额:
$ 1190.91万 - 项目类别:
Intramural
UK Biobank Genetic Analyses Enhancement
英国生物银行基因分析增强
- 批准号:
MC_PC_12028 - 财政年份:2013
- 资助金额:
$ 1190.91万 - 项目类别:
Intramural
Mitochondrial biogenesis and disease
线粒体生物发生和疾病
- 批准号:
MC_PC_12029 - 财政年份:2013
- 资助金额:
$ 1190.91万 - 项目类别:
Intramural
CTSU resubmission: Proposal to increase capacity for methodological improvements in clinical trials
CTSU 重新提交:提高临床试验方法改进能力的提案
- 批准号:
MC_EX_G0801669 - 财政年份:2008
- 资助金额:
$ 1190.91万 - 项目类别:
Research Grant
相似国自然基金
基于微服务设计的Biobank信息化平台系统建设与研发
- 批准号:2020JJ9057
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
相似海外基金
SBIR Phase I: Space Biobank: Enabling High Throughput Space-Based Biotech R&D
SBIR 第一阶段:太空生物库:实现高通量天基生物技术 R
- 批准号:
2419674 - 财政年份:2024
- 资助金额:
$ 1190.91万 - 项目类别:
Standard Grant
An Evaluation of Patient Engagement in the Rare Pediatric Cancer Biobank
罕见儿科癌症生物库中患者参与度的评估
- 批准号:
495165 - 财政年份:2023
- 资助金额:
$ 1190.91万 - 项目类别:
Investigating health risks of environmental stressors in the UK Biobank cohort
调查英国生物银行队列中环境压力因素的健康风险
- 批准号:
MR/Y003330/1 - 财政年份:2023
- 资助金额:
$ 1190.91万 - 项目类别:
Research Grant
Establishment of a multi-center biobank of patient-specific induced pluripotent stem cells for pediatric sepsis research
建立用于儿童脓毒症研究的患者特异性诱导多能干细胞多中心生物库
- 批准号:
10649014 - 财政年份:2023
- 资助金额:
$ 1190.91万 - 项目类别:
Treatment development for refractory leukemia using childhood/adolescent, and young adult leukemia biobank
利用儿童/青少年和青年白血病生物库开发难治性白血病的治疗方法
- 批准号:
23K07305 - 财政年份:2023
- 资助金额:
$ 1190.91万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Integrative genomic and geospatial analysis of insurance claim, biobank and GWAS summary statistics for complex traits
保险索赔的综合基因组和地理空间分析、生物库和复杂性状的 GWAS 汇总统计
- 批准号:
10595104 - 财政年份:2023
- 资助金额:
$ 1190.91万 - 项目类别:
Biobank of small extracellular vesicles for pediatric sepsis
小儿脓毒症小细胞外囊泡生物库
- 批准号:
10740537 - 财政年份:2023
- 资助金额:
$ 1190.91万 - 项目类别:
High-grade serous ovarian cancer: exploiting a living biobank to delineate mechanisms underlying disease-specific chromosome instability
高级别浆液性卵巢癌:利用活生物库来描述疾病特异性染色体不稳定的机制
- 批准号:
MR/X008088/1 - 财政年份:2023
- 资助金额:
$ 1190.91万 - 项目类别:
Research Grant
Deep learning analysis of genes for sarcopenia in large-scale biobank MRI images
大规模生物库 MRI 图像中肌肉减少症基因的深度学习分析
- 批准号:
23K15740 - 财政年份:2023
- 资助金额:
$ 1190.91万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Discovery and Characterization of Rare Variant Effects in Dilated Cardiomyopathy via Large-Scale Biobank Analysis
通过大规模生物库分析发现和表征扩张型心肌病的罕见变异效应
- 批准号:
10682290 - 财政年份:2023
- 资助金额:
$ 1190.91万 - 项目类别:














{{item.name}}会员




